Utah Medical Products Inc
UTMD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000706698
No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Utah Medical Products Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 75 | 78 | +3 |
| Shares | 2.56M | 2.54M | −24.0K (−0.9%) |
| Value | $219.9M | $216.3M | −$3.56M (−1.6%) |
New holders (7)
Institutions that held Utah Medical Products Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 342,187 | $29.2M | 0.02% |
| Watershed Asset Management, L.L.C. | 2,850 | $243.0K | 0.32% |
| Citadel Advisors LLC | 2,513 | $214.0K | 0.00% |
| Invesco Ltd. | 2,354 | $201.0K | 0.00% |
| Steward Partners Investment Advisory, LLC | 31 | $3.00K | 0.00% |
| Covestor Ltd | 16 | $1.00K | 0.00% |
| Bourgeon Capital Management LLC | 3 | $0 | 0.00% |
Sold out (4)
Institutions that held Utah Medical Products Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| AQR Capital Management LLC | 5,346 | $459.0K |
| UBS Group AG | 391 | $34.0K |
| UBS Asset Management Americas Inc | 44 | $3.78K |
| Rockefeller Capital Management L.P. | 35 | $3.00K |